Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,109 public trials 1,857 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Not Yet Recruiting

Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.

NCT07051928

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome, Italy

View Trial Details

Not Yet Recruiting

A Safety Study of 212Pb-Pentixather Radioligand Therapy

NCT05557708

Conditions: Bronchial Neoplasms, Carcinoid Tumor Lung, Carcinoma, Bronchogenic, +10 more
Locations: University of Iowa Health Care Iowa City, Iowa, United States

View Trial Details

Not Yet Recruiting

Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy

NCT06974097

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: CHU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier, Cedex 5, France

View Trial Details

Not Yet Recruiting

PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC

NCT07043907

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Primary Resistance Mechanisms of ALK TKIs

NCT07045610

Conditions: ALK-positive Advanced NSCLC Patients, Lung Diseases, Lung Neoplasms, +7 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Not Yet Recruiting

A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC

NCT06977828

Conditions: Adjuvant Immunotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer

NCT07034365

Conditions: Brain Diseases, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Neoplasms, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer

NCT07042867

Conditions: Disease, Lung Cancer (Diagnosis), Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC

NCT06829641

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

NCT07036185

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Respiratory Tract Neoplasms

Respiratory Tract Neoplasms trial results

Related conditions